SUMMARYIn order to elucidate the factors responsible for altered inimunoglobuHn production in patients with IgA nephropalhy (IgAN). the in vitro effeets of IL-4 and interferon-gamma (IFN-y) on the synthesis of IgH and IgA by peripheral blood mononuclcar cells (PBMC) were studied. Spontaneous IgE and IgA synthesis by PBMC was signifieantly increased in palienis with IgA nephropathy compared with eontrols. The maximum amounts of IgA and IgE synthesis by PBMC after stimulation with IL-4 were almost the same both in palients with IgAN and in eontrols. The enhaneemenl rale of IL-4-induced IgE and IgA synthesis was signihcanlly lower in IgAN than in the controls, suggesting in vivo preaetivation of PBMC in IgAN patients. IFN-7 suppressed IgA and IgE synthesis by PBMC from IgAN patients as well as controls. However, the suppressive effect on IgE synthesis was less prominent in patients with IgAN, These results suggested ihat altered IL-4 action might be involved in the development oflgA nephropathy. IgE [18]. In recent studies, increased expression of CD23 on peripheral blood lymphocytes has been reported in asthma [19]. atopic dermatitis [20). and in other atopie diseases [21.22] as well as in collagen diseases sueh as systemic lupus erythcmalosus (SLE) and rheumatic arthritis [23], Other reports showed elevated levels of lL-4 in sera from patients with Correspondence: Naohiro Yano, MI), Department oT Internal Medicine, Tokai University, Isehara, Kanagawa, 259-11, Japan, progressive systemic sclerosis [24], and expression of IL-4 mRNA in allergen-induced late-phase cutaneous reactions in atopie subjects [25], A study using I L-4-transgenie miee revealed thai IL-4 induces allcrgic-like inflammatory disease in systemic organs [26]. These studies strongly suggested that IL-4 plays some role in the development ofdiseases wiih allergie changes. The aim of ihe present study was to elueidate the role of IL-4 in altered production of IgE and IgA by peripheral blood mononuciear cells (PBMC) from patients with IgAN.
Keywords
MATERIALS AND METHODS
PatientsTwenty-six patients with IgAN and 22 age-matched patients with non-IgA prolifcrative glomerulonephrilis (PGN) were selected randomly from patients who were diagnosed by open